Stereotactic body radiotherapy for unresectable cholangiocarcinoma.


PURPOSE To report outcomes of a single institution study of stereotactic body radiotherapy (SBRT) for unresectable cholangiocarcinoma. The dose-volume dependency of the observed gastrointestinal toxicity is explored. METHODS AND MATERIALS Twenty-seven patients with unresectable cholangiocarcinoma (n=26 Klatskin tumours and one intrahepatic… (More)
DOI: 10.1016/j.radonc.2009.11.004

Cite this paper

@article{Kopek2010StereotacticBR, title={Stereotactic body radiotherapy for unresectable cholangiocarcinoma.}, author={Neil Kopek and Marianne Ingerslev Holt and Anders Traberg Hansen and Morten H\oyer}, journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology}, year={2010}, volume={94 1}, pages={47-52} }